PortfoliosLab logo

AcelRx Pharmaceuticals, Inc. (ACRX)

Equity · Currency in USD · Last updated Oct 1, 2022

Company Info

ISINUS00444T1007
CUSIP00444T100
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.23
Year Range$0.18 - $1.07
EMA (50)$0.27
EMA (200)$0.41
Average Volume$2.65M
Market Capitalization$34.27M

ACRXShare Price Chart


Chart placeholderClick Calculate to get results

ACRXPerformance

The chart shows the growth of $10,000 invested in AcelRx Pharmaceuticals, Inc. in Feb 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $459 for a total return of roughly -95.41%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%MayJuneJulyAugustSeptember
-27.94%
-21.76%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-27.93%-10.05%
6M-27.93%-20.85%
YTD-62.68%-24.77%
1Y-79.71%-17.75%
5Y-46.17%7.02%
10Y-23.92%9.38%

ACRXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-14.29%-6.25%-35.56%-13.79%-8.00%4.35%-12.50%42.86%-30.33%
202177.42%-14.55%-9.57%-23.53%6.92%-0.72%-14.49%-5.08%-8.93%-13.73%-26.14%-13.85%
2020-19.43%-22.35%-10.61%36.44%-13.66%-12.95%-9.92%14.68%13.60%20.42%-12.28%-17.33%
20196.49%36.59%3.57%11.21%-33.07%-2.32%3.16%-10.73%-5.58%-9.09%-7.00%13.44%
2018-6.17%-5.26%16.67%14.29%41.67%-0.74%-17.04%10.71%24.19%7.53%-18.60%-31.45%
20171.92%15.09%3.28%-17.46%-3.85%-14.00%81.40%-15.38%39.39%-58.70%14.47%-6.90%
2016-6.23%2.77%-16.98%9.74%2.37%-22.25%34.94%-13.22%23.49%-28.02%10.71%-16.13%
2015-0.45%32.24%-56.43%3.37%-12.28%21.14%-2.83%3.88%-28.74%29.18%45.18%-32.69%
20140.97%0.09%5.07%-9.91%-14.97%11.41%-32.10%2.73%-23.22%20.77%0.45%1.05%
201326.06%-6.89%3.20%13.57%52.05%4.04%25.67%-14.94%8.78%-37.66%45.54%15.64%
201271.87%-14.55%23.76%3.15%-18.06%10.17%-10.15%2.74%6.33%-5.96%42.00%0.00%
2011-20.44%-5.25%-0.29%40.35%-4.38%-10.68%-17.07%-5.59%-7.79%0.90%-35.71%

ACRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AcelRx Pharmaceuticals, Inc. Sharpe ratio is -0.76. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MayJuneJulyAugustSeptember
-0.76
-0.77
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXDividend History


AcelRx Pharmaceuticals, Inc. doesn't pay dividends

ACRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-98.41%
-25.25%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXWorst Drawdowns

The table below shows the maximum drawdowns of the AcelRx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AcelRx Pharmaceuticals, Inc. is 98.63%, recorded on May 12, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.63%Jul 23, 20132218May 12, 2022
-60%Jun 1, 2011135Dec 30, 2011218Nov 26, 2012353
-33.63%Feb 14, 201146Apr 19, 201127May 27, 201173
-33.4%Nov 27, 20128Dec 6, 201229Jan 18, 201337
-21.97%Feb 14, 201323Mar 19, 201316Apr 11, 201339
-15.9%Jun 12, 201310Jun 25, 20135Jul 2, 201315
-10.99%May 17, 20133May 21, 20131May 22, 20134
-9.84%Jan 23, 201312Feb 7, 20134Feb 13, 201316
-9.76%Apr 24, 20136May 1, 20134May 7, 201310
-9.29%Apr 15, 20133Apr 17, 20134Apr 23, 20137

ACRXVolatility Chart

Current AcelRx Pharmaceuticals, Inc. volatility is 92.54%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MayJuneJulyAugustSeptember
92.54%
19.40%
ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)